Vaxart Inc.

NASDAQ: VXRT · Real-Time Price · USD
0.49
-0.04 (-7.98%)
At close: Jun 27, 2025, 3:59 PM

Vaxart Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
25.23M 34.76M 44.01M 143.75M
Short-Term Investments
26.49M 4.96M 49.7M 22.74M
Long-Term Investments
n/a n/a n/a 16.21M
Other Long-Term Assets
60.95M 926K 3.57M 890K
Receivables
11.97M 3.01M 20K 71K
Inventory
n/a n/a 2M n/a
Other Current Assets
318K 333K 3.71M 2.61M
Total Current Assets
68.26M 45.54M 99.45M 169.17M
Property-Plant & Equipment
29.11M 36.57M 41.3M 19.77M
Goodwill & Intangibles
8.06M 8.8M 9.53M 15.13M
Total Long-Term Assets
98.13M 46.29M 54.4M 52M
Total Assets
166.39M 91.83M 153.85M 221.17M
Account Payables
6.96M 1.58M 5.51M 3.87M
Deferred Revenue
65.4M n/a 2M 5.06M
Short-Term Debt
n/a 3.8M 95K n/a
Other Current Liabilities
9.15M 8.38M 5.07M 836K
Total Current Liabilities
90.88M 13.72M 17.92M 10.78M
Long-Term Debt
n/a 2.62M n/a n/a
Other Long-Term Liabilities
2.14M 293K 5.85M 10.86M
Total Long-Term Liabilities
16.59M 20.3M 25.33M 22.85M
Total Liabilities
107.46M 34.02M 43.25M 33.64M
Total Debt
17.53M 20.09M 21.7M 13.01M
Common Stock
23K 15K 13K 13K
Retained Earnings
-476.52M -409.57M -327.11M -219.35M
Comprehensive Income
4K -1K -299K -74K
Shareholders Equity
58.92M 57.8M 110.6M 187.53M
Total Investments
26.49M 4.96M 49.7M 38.95M